TY - JOUR T1 - D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites. JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 361 LP - 368 VL - 233 IS - 2 AU - J A Severson AU - P K Randall Y1 - 1985/05/01 UR - http://jpet.aspetjournals.org/content/233/2/361.abstract N2 - Striatal D-2 dopamine receptors in homogenates from aged male C57BL/6J mice were examined for high and low-affinity agonist binding. High-affinity dopamine binding requires the ternary complex of the D-2 receptor and a guanine nucleotide binding regulatory protein (N). Thus, changes in the interaction of D-2 and N could contribute to previously reported changes in agonist binding in aged rodents and humans. Qualitative experiments indicated no age-change in the ability of guanine nucleotides to reduce the apparent potency of dopamine at D-2 receptors. Also, no age differences were observed in the ability of guanine nucleotides to decrease N-[3H]propylnorapomorphine binding, suggesting that the ability of guanine nucleotides to dissociate D-2 and N was similar with age. Quantitative determination of the high- (RH) and low-affinity (RL) agonist binding components of striatal D-2 dopamine receptors in the absence of guanine nucleotides indicated differences in the density of RH, and the percentage of D-2 receptors measured as RH, between the ages of 3 and 12 months. No changes in RH or percentage of RH occurred after midlife. In contrast, the total D-2 receptor population, [3H]spiperone maximum binding, declined progressively from 3 to 24 months. Age-changes were restricted to D-2 receptor density; the dissociation constants for agonist and antagonist binding were similar across age. The data suggest that age-changes in striatal D-2 dopamine receptors can occur in the density of the D-2 receptor and in the mechanism that confers the property of high-affinity agonist binding upon the D-2 receptor. ER -